• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State.评估专家对物质滥用预防、减少伤害和治疗方面挑战的看法,以确定纽约州的资金优先事项。
Harm Reduct J. 2024 Jul 15;21(1):134. doi: 10.1186/s12954-024-01045-3.
2
How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.我们如何理解药物检测作为减少伤害服务的一部分的价值?对客户和服务提供者观点的定性探讨。
Harm Reduct J. 2024 May 11;21(1):92. doi: 10.1186/s12954-024-01014-w.
3
Harm Reduction in the Field: First Responders' Perceptions of Opioid Overdose Interventions.现场减少伤害:急救人员对阿片类药物过量干预的看法。
West J Emerg Med. 2024 Jul;25(4):490-499. doi: 10.5811/westjem.18033.
4
Harm Reduction in Health Care Settings.医疗环境中的危害减少。
Med Clin North Am. 2022 Jan;106(1):201-217. doi: 10.1016/j.mcna.2021.09.002.
5
"We do it ourselves": strengths and opportunities for improving the practice of harm reduction.“我们自己动手”:加强和拓展减少伤害实践的优势与机遇。
Harm Reduct J. 2023 Jun 9;20(1):70. doi: 10.1186/s12954-023-00809-7.
6
'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harms.“社区正在努力应对这场危机”:关于预防和减少阿片类药物相关危害的社区计划的范围界定审查
BMJ Open. 2019 Sep 12;9(9):e028583. doi: 10.1136/bmjopen-2018-028583.
7
Perspectives of key interest groups regarding supervised Consumption sites (SCS) and novel virtual harm reduction services / overdose response hotlines and applications: a qualitative Canadian study.关键利益相关群体对监督消费场所 (SCS) 和新型虚拟减少伤害服务/ 过量反应热线和应用的看法:一项加拿大定性研究。
Harm Reduct J. 2024 Jul 27;21(1):141. doi: 10.1186/s12954-024-01053-3.
8
Assessing Knowledge of Opioid Misuse and Harm Reduction: A Community Partner Collaboration.评估阿片类药物滥用和减少伤害的知识:社区合作伙伴合作。
J Allied Health. 2021 Fall;50(3):229-233.
9
Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.鸣哨与减少伤害:一项定性研究,旨在确定女性吸毒者在预防药物过量方面的差距。
Harm Reduct J. 2021 Mar 7;18(1):29. doi: 10.1186/s12954-021-00479-3.
10
Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder.管理式医疗药房团队针对物质使用障碍人群采取的减少伤害协作方法。
J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):396-402. doi: 10.1016/j.japh.2022.10.029. Epub 2022 Nov 30.

引用本文的文献

1
Substance Use Treatment Services in New York (2021-2023): A State Profile Analysis Based on National Survey of Substance Abuse and Mental Health Services (N-SUMHSS) Data.纽约的物质使用治疗服务(2021 - 2023年):基于全国物质滥用和心理健康服务调查(N - SUMHSS)数据的州概况分析
Cureus. 2025 May 13;17(5):e84029. doi: 10.7759/cureus.84029. eCollection 2025 May.

本文引用的文献

1
Structural stigma within inpatient care for people who inject drugs: implications for harm reduction.住院治疗中针对吸毒者的结构性污名:对减少伤害的影响。
Harm Reduct J. 2024 Feb 27;21(1):53. doi: 10.1186/s12954-024-00971-6.
2
"They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.“他们设置了太多的障碍和繁琐的程序”:在阿片类药物过量流行期间,药物治疗面临的系统和组织障碍。
Harm Reduct J. 2024 Feb 27;21(1):52. doi: 10.1186/s12954-024-00964-5.
3
Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study.医学专业学术文献:医学专业培训项目中对物质使用障碍污名的教师、员工和学生认知:一项定量研究
Subst Abuse Treat Prev Policy. 2023 Jan 6;18(1):2. doi: 10.1186/s13011-022-00509-8.
4
A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder.一项关于患者对物质使用障碍治疗的可及性、依从性、耻辱感和持续性方面的障碍及促进因素观点的系统文献综述。
Explor Res Clin Soc Pharm. 2021 Jun 4;2:100029. doi: 10.1016/j.rcsop.2021.100029. eCollection 2021 Jun.
5
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.污名对阿片类药物使用障碍患者、阿片类药物治疗及政策的影响
Subst Abuse Rehabil. 2022 Jan 25;13:1-12. doi: 10.2147/SAR.S304566. eCollection 2022.
6
Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.将医疗补助政策转化为实践:三个美国州在加强物质使用障碍治疗方面的政策实施策略经验。
Implement Sci. 2022 Jan 6;17(1):3. doi: 10.1186/s13012-021-01182-4.
7
The mediating role of perceived social support in the relationship between perceived stigma and depression among individuals diagnosed with substance use disorders.感知到的社会支持在物质使用障碍患者感知污名与抑郁之间关系中的中介作用。
J Psychiatr Ment Health Nurs. 2022 Apr;29(2):307-316. doi: 10.1111/jpm.12794. Epub 2021 Sep 9.
8
Payer-Provider Partnership to Identify Successful Retention Strategies for the Behavioral Health Workforce.支付方-服务提供方合作关系,以确定行为健康劳动力的成功保留策略。
Prog Community Health Partnersh. 2021;15(2):151-160. doi: 10.1353/cpr.2021.0018.
9
A systematic review of stigma interventions for providers who treat patients with substance use disorders.对治疗物质使用障碍患者的医护人员的污名干预措施的系统评价。
J Subst Abuse Treat. 2021 Dec;131:108486. doi: 10.1016/j.jsat.2021.108486. Epub 2021 May 25.
10
Difficult binds: A systematic review of facilitators and barriers to treatment among mothers with substance use disorders.困境重重:物质使用障碍母亲治疗的促进因素和障碍的系统评价。
J Subst Abuse Treat. 2021 Jul;126:108341. doi: 10.1016/j.jsat.2021.108341. Epub 2021 Feb 27.

评估专家对物质滥用预防、减少伤害和治疗方面挑战的看法,以确定纽约州的资金优先事项。

Assessing experts' perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State.

机构信息

Department of Emergency Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, University at Buffalo Gateway Building, Suite 420, 77 Goodell St., Buffalo, NY, 14203, USA.

Department of Community Health and Health Behavior, School of Public Health and Health Professions, University at Buffalo, 3435 Main Street, Buffalo, NY, 14214, USA.

出版信息

Harm Reduct J. 2024 Jul 15;21(1):134. doi: 10.1186/s12954-024-01045-3.

DOI:10.1186/s12954-024-01045-3
PMID:39004729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247824/
Abstract

BACKGROUND

Drug overdose is a leading cause of death and opioid-related deaths increased by more than 300% from 2010 to 2020 in New York State. Experts holding a range of senior leadership positions from across New York State were asked to identify the greatest challenges in substance misuse prevention, harm reduction, and treatment continuum of care. Expert input was used to shape funding priorities.

METHOD

Individual semi-structured interviews of sixteen experts were conducted in April and May 2023. Experts included academics, medical directors, leaders of substance misuse service agencies, administrators of a state agency, a county mental health commissioner, the president of a pharmacy chain, and a senior vice president of an addiction-related national non-profit. Zoom interviews were conducted individually by an experienced qualitative interviewer and were recorded, transcribed, and coded for content. An initial report, with the results of the interviews organized by thematic content, was reviewed by the research team and emailed to the expert interviewees for feedback.

RESULTS

The research team identified five major themes: 1. Siloed and fragmented care delivery systems; 2. Need for a skilled workforce; 3. Attitudes towards addiction (stigma); 4. Limitations in treatment access; and 5. Social and drug related environmental factors. Most experts identified challenges in each major theme; over three-quarters identified issues related to siloed and fragmented systems and the need for a skilled workforce. Each expert mentioned more than one theme, three experts mentioned all five themes and six experts mentioned four themes.

CONCLUSIONS

Research, educational, and programmatic agendas should focus on identified topics as a means of improving the lives of patients at risk for or suffering from substance use-related disorders. The results of this project informed funding of pilot interventions designed to address the identified care challenges.

摘要

背景

药物过量是导致死亡的主要原因,在纽约州,2010 年至 2020 年期间,与阿片类药物相关的死亡人数增加了 300%以上。来自纽约州各地的一系列高级领导职位的专家被要求确定在物质滥用预防、减少伤害和治疗连续体方面最大的挑战。专家的意见被用于确定资金优先事项。

方法

在 2023 年 4 月和 5 月,对 16 名专家进行了单独的半结构化访谈。专家包括学者、医学主任、药物滥用服务机构的领导、州机构的管理人员、县心理健康专员、连锁药店的总裁和一个与成瘾相关的全国性非营利组织的高级副总裁。经验丰富的定性访谈者单独进行了 Zoom 访谈,并对访谈进行了录音、转录和编码,以获取内容。研究小组审查了一份初步报告,该报告根据主题内容组织了访谈结果,并将报告发送给接受采访的专家,以征求他们的反馈意见。

结果

研究小组确定了五个主要主题:1. 分散和碎片化的护理提供系统;2. 需要熟练的劳动力;3. 对成瘾的态度(污名);4. 治疗机会的限制;5. 社会和药物相关的环境因素。大多数专家都确定了每个主要主题中的挑战;超过四分之三的专家提到了分散和碎片化系统以及需要熟练劳动力的问题。每位专家都提到了不止一个主题,三位专家提到了所有五个主题,六位专家提到了四个主题。

结论

研究、教育和项目议程应集中在已确定的主题上,以改善有风险或患有物质使用相关障碍的患者的生活。该项目的结果为资助试点干预措施提供了信息,这些干预措施旨在解决已确定的护理挑战。